<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>Chapter 6 Acid-base &amp; chloride | Nephromaths</title>
  <meta name="description" content="How to use blood and urine electrolytes to diagnose and treat electrolyte and acid-base disorders." />
  <meta name="generator" content="bookdown 0.22 and GitBook 2.6.7" />

  <meta property="og:title" content="Chapter 6 Acid-base &amp; chloride | Nephromaths" />
  <meta property="og:type" content="book" />
  <meta property="og:url" content="https://nephrobooks.netlify.com" />
  
  <meta property="og:description" content="How to use blood and urine electrolytes to diagnose and treat electrolyte and acid-base disorders." />
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Chapter 6 Acid-base &amp; chloride | Nephromaths" />
  
  <meta name="twitter:description" content="How to use blood and urine electrolytes to diagnose and treat electrolyte and acid-base disorders." />
  

<meta name="author" content="Robert W Hunter" />


<meta name="date" content="2021-08-07" />

  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="potassium.html"/>
<link rel="next" href="phosphate.html"/>
<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />









<link href="libs/anchor-sections-1.0.1/anchor-sections.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.0.1/anchor-sections.js"></script>
<script src="libs/kePrint-0.0.1/kePrint.js"></script>
<link href="libs/bsTable-3.3.7/bootstrapTable.min.css" rel="stylesheet" />




<link rel="stylesheet" href="style_RWH.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="https://www.kidneyfish.net">KidneyFish</a></li>
<li><a href="./">Nephromaths</a></li>

<li class="divider"></li>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>Disclaimer</a></li>
<li class="chapter" data-level="" data-path="acknowledgements.html"><a href="acknowledgements.html"><i class="fa fa-check"></i>Acknowledgements</a></li>
<li class="chapter" data-level="1" data-path="intro.html"><a href="intro.html"><i class="fa fa-check"></i><b>1</b> Introduction</a><ul>
<li class="chapter" data-level="1.1" data-path="intro.html"><a href="intro.html#work-in-progress"><i class="fa fa-check"></i><b>1.1</b> Work in progress</a></li>
<li class="chapter" data-level="1.2" data-path="intro.html"><a href="intro.html#what-this-book-is---and-what-it-is-not"><i class="fa fa-check"></i><b>1.2</b> What this book is - and what it is not</a></li>
<li class="chapter" data-level="1.3" data-path="intro.html"><a href="intro.html#how-to-use-this-book"><i class="fa fa-check"></i><b>1.3</b> How to use this book</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="basic-concepts.html"><a href="basic-concepts.html"><i class="fa fa-check"></i><b>2</b> Basic Concepts</a><ul>
<li class="chapter" data-level="2.1" data-path="basic-concepts.html"><a href="basic-concepts.html#validity"><i class="fa fa-check"></i><b>2.1</b> Validity &amp; assumptions</a></li>
<li class="chapter" data-level="2.2" data-path="basic-concepts.html"><a href="basic-concepts.html#general-principles"><i class="fa fa-check"></i><b>2.2</b> General principles</a><ul>
<li class="chapter" data-level="2.2.1" data-path="basic-concepts.html"><a href="basic-concepts.html#balance"><i class="fa fa-check"></i><b>2.2.1</b> Balance</a></li>
<li class="chapter" data-level="2.2.2" data-path="basic-concepts.html"><a href="basic-concepts.html#testing-during-stress-normal-ranges"><i class="fa fa-check"></i><b>2.2.2</b> Testing during stress &amp; “normal ranges”</a></li>
<li class="chapter" data-level="2.2.3" data-path="basic-concepts.html"><a href="basic-concepts.html#renal-clearance-fractional-excretion"><i class="fa fa-check"></i><b>2.2.3</b> Renal clearance &amp; fractional excretion</a></li>
<li class="chapter" data-level="2.2.4" data-path="basic-concepts.html"><a href="basic-concepts.html#tmax"><i class="fa fa-check"></i><b>2.2.4</b> Tmax</a></li>
<li class="chapter" data-level="2.2.5" data-path="basic-concepts.html"><a href="basic-concepts.html#tonicity"><i class="fa fa-check"></i><b>2.2.5</b> Osmolarity, osmolality &amp; tonicity</a></li>
<li class="chapter" data-level="2.2.6" data-path="basic-concepts.html"><a href="basic-concepts.html#gaps"><i class="fa fa-check"></i><b>2.2.6</b> Gaps</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="3" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html"><i class="fa fa-check"></i><b>3</b> General approach to a patient with electrolyte disturbance</a><ul>
<li class="chapter" data-level="3.1" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#vomit"><i class="fa fa-check"></i><b>3.1</b> Vomiting &amp; diarrhoea</a><ul>
<li class="chapter" data-level="3.1.1" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#electrolyte-content-of-gi-fluids"><i class="fa fa-check"></i><b>3.1.1</b> Electrolyte content of GI fluids</a></li>
<li class="chapter" data-level="3.1.2" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#vomiting"><i class="fa fa-check"></i><b>3.1.2</b> Vomiting</a></li>
<li class="chapter" data-level="3.1.3" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#quantitative-assessment-after-vomiting"><i class="fa fa-check"></i><b>3.1.3</b> Quantitative assessment after vomiting</a></li>
<li class="chapter" data-level="3.1.4" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#diarrhoea"><i class="fa fa-check"></i><b>3.1.4</b> Diarrhoea</a></li>
</ul></li>
<li class="chapter" data-level="3.2" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#drugs"><i class="fa fa-check"></i><b>3.2</b> Drugs</a></li>
<li class="chapter" data-level="3.3" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#iv-fluids-electrolyte-supplements"><i class="fa fa-check"></i><b>3.3</b> IV fluids &amp; electrolyte supplements</a></li>
<li class="chapter" data-level="3.4" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#diet"><i class="fa fa-check"></i><b>3.4</b> Diet</a></li>
<li class="chapter" data-level="3.5" data-path="general-approach-to-a-patient-with-electrolyte-disturbance.html"><a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#basic-set-of-investigations"><i class="fa fa-check"></i><b>3.5</b> Basic set of investigations</a></li>
</ul></li>
<li class="chapter" data-level="4" data-path="water-and-sodium.html"><a href="water-and-sodium.html"><i class="fa fa-check"></i><b>4</b> Water and sodium</a><ul>
<li class="chapter" data-level="4.1" data-path="water-and-sodium.html"><a href="water-and-sodium.html#total-body-water"><i class="fa fa-check"></i><b>4.1</b> Total body water</a></li>
<li class="chapter" data-level="4.2" data-path="water-and-sodium.html"><a href="water-and-sodium.html#plasma-sodium"><i class="fa fa-check"></i><b>4.2</b> Plasma sodium</a></li>
<li class="chapter" data-level="4.3" data-path="water-and-sodium.html"><a href="water-and-sodium.html#renal-water-excretion"><i class="fa fa-check"></i><b>4.3</b> Renal water excretion</a></li>
<li class="chapter" data-level="4.4" data-path="water-and-sodium.html"><a href="water-and-sodium.html#UOsm"><i class="fa fa-check"></i><b>4.4</b> Urine osmolality</a></li>
<li class="chapter" data-level="4.5" data-path="water-and-sodium.html"><a href="water-and-sodium.html#hyponatraemia"><i class="fa fa-check"></i><b>4.5</b> Hyponatraemia</a><ul>
<li class="chapter" data-level="4.5.1" data-path="water-and-sodium.html"><a href="water-and-sodium.html#drug-causes-of-hyponatraemia"><i class="fa fa-check"></i><b>4.5.1</b> Drug causes of hyponatraemia</a></li>
<li class="chapter" data-level="4.5.2" data-path="water-and-sodium.html"><a href="water-and-sodium.html#correction-for-hyperglycaemia"><i class="fa fa-check"></i><b>4.5.2</b> Correction for hyperglycaemia</a></li>
<li class="chapter" data-level="4.5.3" data-path="water-and-sodium.html"><a href="water-and-sodium.html#urine-sodium"><i class="fa fa-check"></i><b>4.5.3</b> Urine sodium</a></li>
<li class="chapter" data-level="4.5.4" data-path="water-and-sodium.html"><a href="water-and-sodium.html#feurate-as-an-alternative-index-of-volume-status"><i class="fa fa-check"></i><b>4.5.4</b> FE<sub>urate</sub> as an alternative index of volume status</a></li>
</ul></li>
<li class="chapter" data-level="4.6" data-path="water-and-sodium.html"><a href="water-and-sodium.html#free-water-clearance"><i class="fa fa-check"></i><b>4.6</b> Free water clearance</a><ul>
<li class="chapter" data-level="4.6.1" data-path="water-and-sodium.html"><a href="water-and-sodium.html#calculating-free-water-clearance"><i class="fa fa-check"></i><b>4.6.1</b> Calculating free water clearance</a></li>
<li class="chapter" data-level="4.6.2" data-path="water-and-sodium.html"><a href="water-and-sodium.html#clinical-utility-of-free-water-clearance"><i class="fa fa-check"></i><b>4.6.2</b> Clinical utility of free water clearance</a></li>
<li class="chapter" data-level="4.6.3" data-path="water-and-sodium.html"><a href="water-and-sodium.html#drug-causes-of-hyponatraemia-1"><i class="fa fa-check"></i><b>4.6.3</b> Drug causes of hyponatraemia</a></li>
</ul></li>
<li class="chapter" data-level="4.7" data-path="water-and-sodium.html"><a href="water-and-sodium.html#hypernatraemia"><i class="fa fa-check"></i><b>4.7</b> Hypernatraemia</a></li>
</ul></li>
<li class="chapter" data-level="5" data-path="potassium.html"><a href="potassium.html"><i class="fa fa-check"></i><b>5</b> Potassium</a><ul>
<li class="chapter" data-level="5.1" data-path="potassium.html"><a href="potassium.html#quantification"><i class="fa fa-check"></i><b>5.1</b> Quantification</a><ul>
<li class="chapter" data-level="5.1.1" data-path="potassium.html"><a href="potassium.html#interpretation"><i class="fa fa-check"></i><b>5.1.1</b> Interpretation</a></li>
</ul></li>
<li class="chapter" data-level="5.2" data-path="potassium.html"><a href="potassium.html#TTKG"><i class="fa fa-check"></i><b>5.2</b> TTKG</a><ul>
<li class="chapter" data-level="" data-path="potassium.html"><a href="potassium.html#assumptions-pre-requisites"><i class="fa fa-check"></i>Assumptions &amp; pre-requisites</a></li>
<li class="chapter" data-level="" data-path="potassium.html"><a href="potassium.html#interpretation-1"><i class="fa fa-check"></i>Interpretation</a></li>
</ul></li>
<li class="chapter" data-level="5.3" data-path="potassium.html"><a href="potassium.html#hypokalaemia"><i class="fa fa-check"></i><b>5.3</b> Hypokalaemia</a><ul>
<li class="chapter" data-level="5.3.1" data-path="potassium.html"><a href="potassium.html#causes-of-hypokalaemia"><i class="fa fa-check"></i><b>5.3.1</b> Causes of hypokalaemia</a></li>
<li class="chapter" data-level="5.3.2" data-path="potassium.html"><a href="potassium.html#causes-of-k-loss"><i class="fa fa-check"></i><b>5.3.2</b> Causes of K loss</a></li>
<li class="chapter" data-level="5.3.3" data-path="potassium.html"><a href="potassium.html#vomiting-1"><i class="fa fa-check"></i><b>5.3.3</b> Vomiting</a></li>
<li class="chapter" data-level="5.3.4" data-path="potassium.html"><a href="potassium.html#non-reasbsorbable-anions"><i class="fa fa-check"></i><b>5.3.4</b> Non-reasbsorbable anions</a></li>
<li class="chapter" data-level="5.3.5" data-path="potassium.html"><a href="potassium.html#hypokalaemic-periodic-paralysis"><i class="fa fa-check"></i><b>5.3.5</b> Hypokalaemic periodic paralysis</a></li>
</ul></li>
<li class="chapter" data-level="5.4" data-path="potassium.html"><a href="potassium.html#hyperkalaemia"><i class="fa fa-check"></i><b>5.4</b> Hyperkalaemia</a><ul>
<li class="chapter" data-level="5.4.1" data-path="potassium.html"><a href="potassium.html#causes-of-hyperkalaemia"><i class="fa fa-check"></i><b>5.4.1</b> Causes of hyperkalaemia</a></li>
<li class="chapter" data-level="5.4.2" data-path="potassium.html"><a href="potassium.html#drug-causes-of-hyperkalaemia"><i class="fa fa-check"></i><b>5.4.2</b> Drug causes of hyperkalaemia</a></li>
<li class="chapter" data-level="5.4.3" data-path="potassium.html"><a href="potassium.html#causes-of-spurious-hyperkalaemia"><i class="fa fa-check"></i><b>5.4.3</b> Causes of spurious hyperkalaemia</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="6" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html"><i class="fa fa-check"></i><b>6</b> Acid-base &amp; chloride</a><ul>
<li class="chapter" data-level="6.1" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#normal-ranges"><i class="fa fa-check"></i><b>6.1</b> Normal ranges</a></li>
<li class="chapter" data-level="6.2" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#adaptation"><i class="fa fa-check"></i><b>6.2</b> Adaptation</a></li>
<li class="chapter" data-level="6.3" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#metabolic-alkalosis-chloride-homeostasis"><i class="fa fa-check"></i><b>6.3</b> Metabolic alkalosis (&amp; chloride homeostasis)</a><ul>
<li class="chapter" data-level="6.3.1" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#causes-of-a-metabolic-alkalosis"><i class="fa fa-check"></i><b>6.3.1</b> Causes of a metabolic alkalosis</a></li>
<li class="chapter" data-level="6.3.2" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#chloride"><i class="fa fa-check"></i><b>6.3.2</b> Chloride</a></li>
</ul></li>
<li class="chapter" data-level="6.4" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#metabolic-acidosis"><i class="fa fa-check"></i><b>6.4</b> Metabolic acidosis</a><ul>
<li class="chapter" data-level="6.4.1" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#anion-osmolar-gaps"><i class="fa fa-check"></i><b>6.4.1</b> Anion &amp; osmolar gaps</a></li>
<li class="chapter" data-level="6.4.2" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#causes-of-a-metabolic-acidosis"><i class="fa fa-check"></i><b>6.4.2</b> Causes of a metabolic acidosis</a></li>
<li class="chapter" data-level="6.4.3" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#cautions-in-the-interpretation-of-uag"><i class="fa fa-check"></i><b>6.4.3</b> Cautions in the interpretation of UAG</a></li>
</ul></li>
<li class="chapter" data-level="6.5" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#renal-tubular-acidosis"><i class="fa fa-check"></i><b>6.5</b> Renal tubular acidosis</a><ul>
<li class="chapter" data-level="6.5.1" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#classification-of-rta"><i class="fa fa-check"></i><b>6.5.1</b> Classification of RTA</a></li>
<li class="chapter" data-level="6.5.2" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#associations"><i class="fa fa-check"></i><b>6.5.2</b> Associations</a></li>
<li class="chapter" data-level="6.5.3" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#investigation-of-suspected-rta"><i class="fa fa-check"></i><b>6.5.3</b> Investigation of suspected RTA</a></li>
<li class="chapter" data-level="6.5.4" data-path="acid-base-chloride.html"><a href="acid-base-chloride.html#causes"><i class="fa fa-check"></i><b>6.5.4</b> Causes</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="7" data-path="phosphate.html"><a href="phosphate.html"><i class="fa fa-check"></i><b>7</b> Phosphate</a><ul>
<li class="chapter" data-level="7.1" data-path="phosphate.html"><a href="phosphate.html#TMPGFR"><i class="fa fa-check"></i><b>7.1</b> Measuring urinary phosphate and calculating TmP/GFR</a><ul>
<li class="chapter" data-level="7.1.1" data-path="phosphate.html"><a href="phosphate.html#reference-ranges"><i class="fa fa-check"></i><b>7.1.1</b> Reference ranges</a></li>
</ul></li>
<li class="chapter" data-level="7.2" data-path="phosphate.html"><a href="phosphate.html#causes-of-hypophosphataemia"><i class="fa fa-check"></i><b>7.2</b> Causes of hypophosphataemia</a></li>
</ul></li>
<li class="chapter" data-level="8" data-path="calcium.html"><a href="calcium.html"><i class="fa fa-check"></i><b>8</b> Calcium</a><ul>
<li class="chapter" data-level="8.1" data-path="calcium.html"><a href="calcium.html#investigations-in-hypercalcaemia"><i class="fa fa-check"></i><b>8.1</b> Investigations in hypercalcaemia:</a></li>
<li class="chapter" data-level="8.2" data-path="calcium.html"><a href="calcium.html#urine-calcium"><i class="fa fa-check"></i><b>8.2</b> Urine calcium</a></li>
<li class="chapter" data-level="8.3" data-path="calcium.html"><a href="calcium.html#interpreting-the-results"><i class="fa fa-check"></i><b>8.3</b> Interpreting the results</a><ul>
<li class="chapter" data-level="8.3.1" data-path="calcium.html"><a href="calcium.html#unit-conversions"><i class="fa fa-check"></i><b>8.3.1</b> Unit conversions</a></li>
<li class="chapter" data-level="8.3.2" data-path="calcium.html"><a href="calcium.html#normal-calcium-excretion"><i class="fa fa-check"></i><b>8.3.2</b> Normal calcium excretion:</a></li>
<li class="chapter" data-level="8.3.3" data-path="calcium.html"><a href="calcium.html#hypercalciuria-e.g.in-hyperpth-other-causes-of-hypercalcaemia-rta"><i class="fa fa-check"></i><b>8.3.3</b> Hypercalciuria (e.g. in hyperPTH, other causes of hypercalcaemia, RTA):</a></li>
<li class="chapter" data-level="8.3.4" data-path="calcium.html"><a href="calcium.html#hypocalciuria-e.g.fhh-gitelman"><i class="fa fa-check"></i><b>8.3.4</b> Hypocalciuria (e.g. FHH, Gitelman):</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="9" data-path="magnesium.html"><a href="magnesium.html"><i class="fa fa-check"></i><b>9</b> Magnesium</a><ul>
<li class="chapter" data-level="9.1" data-path="magnesium.html"><a href="magnesium.html#differential-diagnosis-of-hypomagesaemia"><i class="fa fa-check"></i><b>9.1</b> Differential diagnosis of hypomagesaemia</a></li>
</ul></li>
<li class="appendix"><span><b>Appendices</b></span></li>
<li class="chapter" data-level="A" data-path="app1.html"><a href="app1.html"><i class="fa fa-check"></i><b>A</b> Appendix 1 - notation &amp; abbreviations</a><ul>
<li class="chapter" data-level="A.1" data-path="app1.html"><a href="app1.html#notation"><i class="fa fa-check"></i><b>A.1</b> Notation</a></li>
<li class="chapter" data-level="A.2" data-path="app1.html"><a href="app1.html#glossary-of-abbreviations"><i class="fa fa-check"></i><b>A.2</b> Glossary of abbreviations</a></li>
</ul></li>
<li class="chapter" data-level="B" data-path="app2.html"><a href="app2.html"><i class="fa fa-check"></i><b>B</b> Appendix 2 - corollaries of urine osmolality equation</a><ul>
<li class="chapter" data-level="B.1" data-path="app2.html"><a href="app2.html#why-drinking-seawater-causes-dehydration"><i class="fa fa-check"></i><b>B.1</b> Why drinking seawater causes dehydration</a></li>
<li class="chapter" data-level="B.2" data-path="app2.html"><a href="app2.html#why-giving-0.9-nacl-can-exacerbate-hyponatraemia-in-some-circumstances"><i class="fa fa-check"></i><b>B.2</b> Why giving 0.9% NaCl can exacerbate hyponatraemia in some circumstances</a></li>
<li class="chapter" data-level="B.3" data-path="app2.html"><a href="app2.html#calculating-the-water-intake-required-to-cause-hyponatraemia"><i class="fa fa-check"></i><b>B.3</b> Calculating the water intake required to cause hyponatraemia</a></li>
<li class="chapter" data-level="B.4" data-path="app2.html"><a href="app2.html#why-poor-diet-low-dietary-solute-intake-can-cause-hyponatraemia"><i class="fa fa-check"></i><b>B.4</b> Why poor diet (low dietary solute intake) can cause hyponatraemia</a></li>
</ul></li>
<li class="chapter" data-level="C" data-path="appendix-3-references.html"><a href="appendix-3-references.html"><i class="fa fa-check"></i><b>C</b> Appendix 3 - references</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Nephromaths</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="acid-base-chloride" class="section level1">
<h1><span class="header-section-number">Chapter 6</span> Acid-base &amp; chloride</h1>
<div id="normal-ranges" class="section level2">
<h2><span class="header-section-number">6.1</span> Normal ranges</h2>
<ul>
<li>pH: <em>7.35 – 7.45</em></li>
<li>PaCO<sub>2</sub>: <em>4.6 – 6.0 kPa; 1 kPa = 7.5 mmHg</em></li>
<li>HCO<sub>3</sub>: <em>22 – 30 mM</em></li>
<li>BE: <em>± 2 mM</em></li>
</ul>

<div class="eqnpanel">
<p><span class="math display" id="eq:pH1">\[\begin{equation}
  pH=-log[H^{+}]
  \tag{6.1}
\end{equation}\]</span></p>
<span class="math display" id="eq:pH2">\[\begin{equation}
  H^{+} = 10^{pH}
  \tag{6.2}
\end{equation}\]</span>
</div>

</div>
<div id="adaptation" class="section level2">
<h2><span class="header-section-number">6.2</span> Adaptation</h2>
<p>Metabolic adaptation to respiratory alkalosis:</p>
<ul>
<li>acute (5 – 10 mins) HCO<sub>3</sub> 16 – 18 mM <em>buffering by serum HCO<sub>3</sub></em></li>
<li>chronic (2 – 3 days) HCO<sub>3</sub> 12 – 15 mM <em>renal excretion of HCO3</em></li>
</ul>
<p>Respiratory adaptation:</p>
<ul>
<li>for each mM HCO<sub>3</sub> &lt; 25 PaCO<sub>2</sub> should drop by… 0.16 kPa (1.2 mmHg)</li>
<li>for each mM HCO<sub>3</sub> &gt; 25 PaCO<sub>2</sub> should rise by… 0.08 kPa (0.6 mmHg)</li>
<li>Winter’s formula: PaCO2 (mmHg) = (1.5 × HCO<sub>3</sub>) + 8 +/- 2 <em>(in metabolic acidosis)</em></li>
</ul>
</div>
<div id="metabolic-alkalosis-chloride-homeostasis" class="section level2">
<h2><span class="header-section-number">6.3</span> Metabolic alkalosis (&amp; chloride homeostasis)</h2>
<div id="causes-of-a-metabolic-alkalosis" class="section level3">
<h3><span class="header-section-number">6.3.1</span> Causes of a metabolic alkalosis</h3>
<p>The causes of a metabolic alkalosis can be classified as being either due to chloride depletion (and therefore <code>chloride responsive</code>) or due to other causes (<code>chloride resistant</code>) <span class="citation">(Luke &amp; Galla, <a href="appendix-3-references.html#ref-luke2012a">2012</a>)</span>.</p>
<!-- +  low ECF volume = chloride-depletion / contractional = chloride-responsive  -->
<!--     +  *vomiting / NG losses*  -->
<!--     +  *loop / thiazide diuretics \**  -->
<!--     +  *Bartter's / Gitelman's \**  -->
<!--     +  *colonic villous adenoma / congenital chloride diarrhoea / high-volume ileostomy (rare)*   -->
<!-- +  normal ECF volume = chloride-resistant  -->
<!--     +  renal H + loss  -->
<!--         +  *true mineralocorticoid XS (low-renin / high-renin)*  -->
<!--         +  *apparent mineralocorticoid XS (and Liddle's)*  -->
<!--         +  *Cushings*  -->
<!--         +  *post-hypercapnic alkalosis (UCl \< 10 mM)*  -->
<!--         +  *milk-alkali syndrome*   -->
<!--     +  intracellular H + shift  -->
<!--         +  *hypokalaemia*   -->
<table>
<tbody>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;vertical-align: top !important;" rowspan="4">
LOW ECF VOLUME = CHLORIDE-DEPLETION / CHLORIDE-RESPONSIVE
</td>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="2">
GI chloride loss
</td>
<td style="text-align:left;">
vomiting / NG losses
</td>
</tr>
<tr>
<td style="text-align:left;">
colonic villous adenoma / congenital chloride diarrhoea / high-volume ileostomy (rare)
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="2">
renal chloride loss
</td>
<td style="text-align:left;">
loop / thiazide diuretics *
</td>
</tr>
<tr>
<td style="text-align:left;">
Bartter / Gitelman *
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;vertical-align: top !important;" rowspan="6">
NORMAL ECF VOLUME = CHLORIDE-RESISTANT
</td>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="5">
renal H + loss
</td>
<td style="text-align:left;">
true mineralocorticoid XS (low-renin / high-renin)
</td>
</tr>
<tr>
<td style="text-align:left;">
apparent mineralocorticoid XS (and Liddle’s)
</td>
</tr>
<tr>
<td style="text-align:left;">
Cushings
</td>
</tr>
<tr>
<td style="text-align:left;">
post-hypercapnic alkalosis (UCl &lt; 10 mM)
</td>
</tr>
<tr>
<td style="text-align:left;">
milk-alkali syndrome
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;">
intracellular H + shift
</td>
<td style="text-align:left;">
hypokalaemia
</td>
</tr>
</tbody>
</table>
<p>* in chloride-responsive states UCl &lt; 10 mM except where chloride is being lost in the urine (i.e. diuretics / Gitelman / Barrter syndrome).</p>
<p>Post-hypercapnic alkalosis occurs if chronic hypercapnia suddenly corrected (e.g. by mechanical ventilation).</p>
<p>The milk-alkali syndrome is the triad of hypercalcaemia, metabolic alkalosis and ingestion of large quantities of calcium with alkali; hypercalcaemia increases renal bicarbonate reabsorption (exacerbating alkalosis).</p>
</div>
<div id="chloride" class="section level3">
<h3><span class="header-section-number">6.3.2</span> Chloride</h3>
<p>U<sub>Cl</sub> NR = 100 – 250 mmol / 24 hrs</p>
<p>In chloride-responsive alkalosis, UCl &lt; 10 mM:</p>
<ul>
<li>vomiting<br />
</li>
<li>villous adenoma<br />
</li>
<li>congenital chloride diarrhoea<br />
</li>
<li>recent diuretics (pause on clinic day in surruptitious use)</li>
</ul>
<p>In chloride-resistant alkalosis UCl &gt; 10 – 30 mM (and also if chloride loss is due to diuretics / tubulopathies).</p>
<p>UCl is persistently low after vomiting and is therefore a useful test for surreptitious vomiting.</p>
<div id="chloride-depletion-alkalosis" class="section level4">
<h4><span class="header-section-number">6.3.2.1</span> Chloride-depletion alkalosis</h4>
<p>In chloride depletion, reduced ECF volume leads to reduced GFR (less filtered NaHCO<sub>3</sub>) and increased Na reabsorption. Thus NaHCO<sub>3</sub> reabsorption is increased. Increased distal Na reabsorption leads to increased acid excretion. Therefore, after <a href="general-approach-to-a-patient-with-electrolyte-disturbance.html#vomit">vomiting</a>, an acid urine is produced (paradoxically) in the face of a metabolic alkalosis. Treatment is volume expansion with NaCl and correction of hypoK.</p>
</div>
</div>
</div>
<div id="metabolic-acidosis" class="section level2">
<h2><span class="header-section-number">6.4</span> Metabolic acidosis</h2>
<div id="anion-osmolar-gaps" class="section level3">
<h3><span class="header-section-number">6.4.1</span> Anion &amp; osmolar gaps</h3>
<p>Metabolic acidoses are classified as <code>wide-anion-gap</code> (WGMA) or <code>normal-anion-gap</code> (= hyperchloraemic, HCMA). In WGMA, the acidosis is caused by an exogenous acid present in plasma. This is not measured directly, but will manifest as an apparent “anion gap”.</p>

<div class="eqnpanel">
<p><span class="math display" id="eq:AGap">\[\begin{equation}
  \text{anion gap, } AG=P_{Na}-P_{HCO_{3}}-P_{Cl}
  \tag{6.3}
\end{equation}\]</span></p>
<p>NB some people also include P<sub>K</sub> in the calculation.</p>
<p><span class="math display" id="eq:cAGap">\[\begin{equation}
  \text{corrected anion gap, } cAG=AG+\frac{40-P_{albumin}}{4}
  \tag{6.4}
\end{equation}\]</span></p>
NB ADD ON to correct for hypoalbuminaemia.<br />

</div>

<p><img src="figures/cAG.png" /></p>
<p>A normal AG is 12 ± 2 (or 16 ± 2 if include K<sup>+</sup> in the calculation).</p>
<p>‘Deltas’ are calculated by comparing to expected normal values (for AG or HCO<sub>3</sub>).</p>

<div class="eqnpanel">
<p><span class="math display" id="eq:DelAGap">\[\begin{equation}
  \text{delta anion gap, } \Delta AG=AG-12
  \tag{6.5}
\end{equation}\]</span></p>
<p><span class="math display" id="eq:DelHCO">\[\begin{equation}
  \text{delta bicarbonate, } \Delta HCO_{3}=25-P_{HCO{3}}
  \tag{6.6}
\end{equation}\]</span></p>
<p><span class="math display" id="eq:DelRatio">\[\begin{equation}
  \text{delta ratio, } =\frac{\Delta AG}{\Delta HCO_{3}}
  \tag{6.7}
\end{equation}\]</span></p>
<span class="math display" id="eq:deltadelta">\[\begin{equation}
  \text{delta delta, } \Delta \Delta = \Delta AG - \Delta HCO_{3} \text{ (in ketoacidosis)}\\
  \text{delta delta, } \Delta \Delta = (0.6 \times \Delta AG) - \Delta HCO_{3} \text{ (in lactic acidosis)}\\
  \tag{6.8}
\end{equation}\]</span>
</div>

<p>The correction factor (0.6) applied when computing the delta in lactic acidosis is thought to be due to lower renal clearance of lactate (compared to ketone) anions <span class="citation">(Berend <em>et al.</em>, <a href="appendix-3-references.html#ref-berend2014">2014</a>)</span>.</p>
<p>Normal range for delta ratio (ΔAG / ΔHCO<sub>3</sub>) is 1 – 2.</p>
<p>Therefore to interpret delta ratios:</p>
<p><img src="figures/AG2.png" /></p>
<p><code>Osmolar gaps</code> are used to identify exogenous or un-measured osmoles in the plasma (which may be present in a subset of WGMA in which the acid is osmotically active):</p>

<div class="eqnpanel">
<p><span class="math display" id="eq:calcOsm">\[\begin{equation}
  \text{calculated osmolality, } cP_{Osm} =(2\times P_{Na})+P_{urea}+P_{glucose}
  \tag{6.9}
\end{equation}\]</span></p>
<span class="math display" id="eq:Osmgap">\[\begin{equation}
  \text{osmolar gap, } OG = \text{measured } P_{Osm} - cP_{Osm}
  \tag{6.10}
\end{equation}\]</span>
</div>

<p>Historically, it has been technically difficult to measure urinary ammonium. Therefore the <em>urinary</em> anion gap has been used as a proxy measure - either in isolation or in combination with the urinary osmolar gap <span class="citation">(Kraut &amp; Madias, <a href="appendix-3-references.html#ref-kraut2012">2012</a>; Sharma <em>et al.</em>, <a href="appendix-3-references.html#ref-sharma2015">2015</a>)</span>:</p>

<div class="eqnpanel">
<p><span class="math display" id="eq:urineAGap">\[\begin{equation}
  \text{urinary anion gap, } UAG=U_{Na}+U_{K}-U_{Cl}
  \tag{6.11}
\end{equation}\]</span></p>
<p><span class="math display" id="eq:calcUOsm">\[\begin{equation}
  \text{calculated urinary osmolality, } cU_{Osm} = 2 \times (U_{Na}+U_{K})+U_{urea}+U_{glucose}
  \tag{6.12}
\end{equation}\]</span></p>
<p><span class="math display" id="eq:UOsGap">\[\begin{equation}
  \text{urinary osmolar gap, } UOG=\text{measured } U_{Osm} - cU_{Osm}
  \tag{6.13}
\end{equation}\]</span></p>
<p><span class="math display" id="eq:UCat">\[\begin{equation}
  \text{urinary cations, } U_{cations}=\frac{U_{Osm}-U_{urea}-U_{glucose}}{2}
  \tag{6.14}
\end{equation}\]</span></p>
<span class="math display" id="eq:UCalcNH">\[\begin{equation}
  \text{calculated urinary ammonium, } cU_{NH_{4}}\approx UAG \approx \frac{UOG}{2} \approx U_{cations}-(U_{Na}+U_{K})
  \tag{6.15}
\end{equation}\]</span>
</div>

<p>UAG normal range is positive 30 – 50.</p>
</div>
<div id="causes-of-a-metabolic-acidosis" class="section level3">
<h3><span class="header-section-number">6.4.2</span> Causes of a metabolic acidosis</h3>
<div id="approach-to-metabolic-acidosis" class="section level4">
<h4><span class="header-section-number">6.4.2.1</span> Approach to metabolic acidosis</h4>

<div class="algpanel">
<p>Order of investigations in metabolic acidosis:</p>
<ol style="list-style-type: decimal">
<li>cAG – is this a normal or wide gap acidosis?</li>
<li>ΔAG vs ΔHCO<sub>3</sub> in WGMA – is rise in AG proportional to fall in HCO<sub>3</sub> (or is this a mixed metabolic disorder)?<br />
</li>
<li>PaCO<sub>2</sub> – is the fall in PaCO<sub>2</sub> proportional to the fall in HCO<sub>3</sub> (0.16 kPa per mM)?<br />
</li>
<li>+/- OG for a WGMA<br />
</li>
<li>+/- UAG for HCMA<br />
</li>
<li>+/- FEHCO<sub>3</sub> for HCMA with –ve UAG</li>
</ol>
ΔAG / ΔHCO<sub>3</sub> &lt; 1 mixed WGMA / HCMA or urinary ketone losses (DKA)
ΔAG / ΔHCO<sub>3</sub> &gt; 2 mixed WGMA and metabolic alkalosis
</div>

</div>
<div id="wgma" class="section level4">
<h4><span class="header-section-number">6.4.2.2</span> WGMA</h4>
<p>Differential diagnosis of a wide-gap metabolic acidosis:</p>
<!-- +  **G** \* glycols *ethylene glycol; propylene glycol* -->
<!-- +  **O** oxoproline -->
<!-- +  **L** L-lactate *shock, liver disease, metformin, linezolid (several weeks into Rx)* -->
<!-- +  **D** D-lactate *short bowel syndromes* -->
<!-- +  **M** \* methanol -->
<!-- +  **A** aspirin -->
<!-- +  **R** renal failure -->
<!-- +  **K** \*^?^ ketoacidosis -->
<table>
<tbody>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;">
G
</td>
<td style="text-align:left;">
glycols ethylene glycol; propylene glycol *
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;">
O
</td>
<td style="text-align:left;">
oxoproline
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;">
L
</td>
<td style="text-align:left;">
L-lactate shock, liver disease, metformin, linezolid (several weeks into Rx)
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;">
D
</td>
<td style="text-align:left;">
D-lactate short bowel syndromes
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;">
M
</td>
<td style="text-align:left;">
methanol *
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;">
A
</td>
<td style="text-align:left;">
aspirin
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;">
R
</td>
<td style="text-align:left;">
renal failure
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;">
K
</td>
<td style="text-align:left;">
ketoacidosis *(?)
</td>
</tr>
</tbody>
</table>
<p>Propylene glycol (a solvent for parenteral medications: lorazepam, diazepam, phenobarbital) is metabolised to L- and D-lactate.</p>
<p>* WGMA with elevated OG = EtOH ketoacidosis, MeOH and the glycols. The OG is NOT elevated with salicylates. There is a time-dependant conversion from OG to AG following ingestion of toxic alcohol (metabolites are charged and bind to Na).</p>
<!-- Administer fomepizole early (before significant acidosis). Indications for RRT (prefer HD to HF): acidosis, renal failure, EG level \> 50 mg/L. -->
</div>
<div id="HCMA" class="section level4">
<h4><span class="header-section-number">6.4.2.3</span> HCMA (normal gap)</h4>
<p>The approach to HCMA has been extensively reviewed [<span class="citation">Rodríguez Soriano (<a href="appendix-3-references.html#ref-rodriguezsoriano2002">2002</a>)</span>; <span class="citation">Kraut &amp; Madias (<a href="appendix-3-references.html#ref-kraut2012">2012</a>)</span>; <span class="citation">Haque <em>et al.</em> (<a href="appendix-3-references.html#ref-haque2012">2012</a>)</span>; <span class="citation">Sharma <em>et al.</em> (<a href="appendix-3-references.html#ref-sharma2015">2015</a>)</span>).</p>
<p>The causes can be classified using the urinary anion gap <a href="acid-base-chloride.html#eq:urineAGap">(6.11)</a> and the fractional excretion of bicarbonate <a href="acid-base-chloride.html#eq:FEHCO3">(6.16)</a>:</p>
<!-- +  \+ ve U AG (unable to acidify urine) -->
<!--     +  *RTA type I (always)* -->
<!--     +  *RTA type IV (always)* -->
<!--     +  *RTA type II (sometimes) \** -->
<!-- +  -- ve U AG (able to acidify urine)   -->
<!--     +  renal (FEHCO~3~ \> 10 -- 15 %) -->
<!--         +  *RTA type II (sometimes) \** -->
<!--         +  *RTA of renal insufficiency (GFR \> 15)* -->
<!--     +  extrarenal (FEHCO~3~ \<\< 5 % \*\*)   -->
<!--         +  *diarrhoea (GI HCO~3~ loss)* -->
<!--         +  *ureteric diversion* -->
<!--         +  *pancreatic secretions* -->
<!--         +  *biliary secretions* -->
<table>
<tbody>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;vertical-align: top !important;" rowspan="3">
POS U AG (UNABLE TO ACIDIFY URINE)
</td>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="3">
RTA
</td>
<td style="text-align:left;">
RTA type I (always)
</td>
</tr>
<tr>
<td style="text-align:left;">
RTA type IV (always)
</td>
</tr>
<tr>
<td style="text-align:left;">
RTA type II (sometimes) *
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;vertical-align: top !important;" rowspan="6">
NEG U AG (ABLE TO ACIDIFY URINE)
</td>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="2">
renal (FEHCO3 &gt; 10 – 15 %)
</td>
<td style="text-align:left;">
RTA type II (sometimes) *
</td>
</tr>
<tr>
<td style="text-align:left;">
RTA of renal insufficiency (GFR &gt; 15)
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="4">
extrarenal (FEHCO3 &lt;&lt; 5 % **)
</td>
<td style="text-align:left;">
diarrhoea (GI HCO3 loss)
</td>
</tr>
<tr>
<td style="text-align:left;">
ureteric diversion
</td>
</tr>
<tr>
<td style="text-align:left;">
pancreatic secretions
</td>
</tr>
<tr>
<td style="text-align:left;">
biliary secretions
</td>
</tr>
</tbody>
</table>
<p>* The UAG is positive in all distal RTA. It may be positive or negative in proximal RTA.</p>
<p>** FEHCO<sub>3</sub> also &lt; 5 % in dRTA.</p>

<div class="eqnpanel">
<span class="math display" id="eq:FEHCO3">\[\begin{equation}
  FE_{HCO_{3}} = \frac{U_{HCO_{3}}}{P_{HCO_{3}}} \times \frac{P_{Creat}}{U_{Creat}}
  \tag{6.16}
\end{equation}\]</span>
</div>

<p>Hyperchloraemic acidosis may also be caused by iatrogenic <code>chloride excess</code>. This may be particularly pronounced when IV NaCl is used to replace losses of urinary anions that represent a store of “potential bicarbonate” - e.g. ketone bodies or D-lactate <span class="citation">(Sabatini &amp; Kurtzman, <a href="appendix-3-references.html#ref-sabatini2009">2009</a>)</span>.</p>
<p>Historically, TPN was a cause of “hyperalimentation acidosis” (as cationic amino acids were metabolised to sulphuric acid) - but contemporary formulations contain a source of potential bicarbonate (e.g. acetate) to offset this.</p>
</div>
</div>
<div id="cautions-in-the-interpretation-of-uag" class="section level3">
<h3><span class="header-section-number">6.4.3</span> Cautions in the interpretation of UAG</h3>
<ol style="list-style-type: lower-roman">
<li>extreme volume depletion
<ul>
<li>results in low UNa and UCl</li>
<li>low UCl limits NH<sub>4</sub> excretion and may therefore lead to a “spurious” positive UAG in diarrhoea</li>
</ul></li>
<li>ketoacidosis
<ul>
<li>unmeasured anions in the urine (β-hydroxybutyrate and acetoacetone)</li>
<li>may therefore lead to a positive UAG even though urinary NH4+ excretion is increased...</li>
<li>…detect this by measuring the urinary osmolar gap</li>
</ul></li>
<li>glue-sniffing (toluene)
- unmeasured anions in the urine (hippurate)</li>
</ol>
<p>A +ve UAG in the context of <em>alkaline</em> urine could signify bicarbonaturia (post-vomiting, loop diuretics, post-hypercapnoea).</p>
</div>
</div>
<div id="renal-tubular-acidosis" class="section level2">
<h2><span class="header-section-number">6.5</span> Renal tubular acidosis</h2>
<p>Free [H<sup>+</sup>] is nM, but we need to excrete mmoles (1 mmol / kg on Western diet), therefore must be buffered by NH<sub>4</sub>, PO<sub>4</sub>…</p>
<div id="classification-of-rta" class="section level3">
<h3><span class="header-section-number">6.5.1</span> Classification of RTA</h3>
<ul>
<li><p>type II (pRTA) <em>impaired reabsorption of HCO3</em></p></li>
<li>type I (dRTA) <em>inability to secrete acid</em>
<ul>
<li><em>complete dRTA systemic acidosis (impaired ammoniagenesis)</em></li>
<li><em>partial dRTA no acidosis (preserved ammoniagenesis)</em></li>
</ul></li>
<li><p>type IV <em>impaired ammoniagenesis (due to hyperK); deficient aldosterone or CD abnormality</em></p></li>
<li><p>type III (mixed) <em>CA inhibition</em></p></li>
<li><p>RTA in CKD <em>HCMA when GFR &lt; 30; WGMA when GFR &lt; 15</em></p></li>
</ul>
</div>
<div id="associations" class="section level3">
<h3><span class="header-section-number">6.5.2</span> Associations</h3>
<ul>
<li>dRTA CaP stones (alkaline urine, hypocitraturia)<br />
</li>
<li>nephrocalcinosis (in inherited but NOT acquired forms)<br />
</li>
<li>osteoporosis</li>
</ul>
</div>
<div id="investigation-of-suspected-rta" class="section level3">
<h3><span class="header-section-number">6.5.3</span> Investigation of suspected RTA</h3>
<ul>
<li>UAG &amp; FENaHCO<sub>3</sub><br />
</li>
<li>urine pH (never &lt; 5.5 in dRTA)<br />
</li>
<li>in suspected pRTA
<ul>
<li><em>tubular reabsorption of phosphate (TRP = 100 - FEPO<sub>4</sub>) &lt; 85 %</em></li>
<li><em>glycosuria, aminoaciduria, LMW proteinuria</em><br />
</li>
</ul></li>
<li>in suspected dRTA
<ul>
<li><em>furosemide-fludrocortisone (FF) test (failure to achieve pH &lt; 5.3 , 3 – 4 hrs after 40 – 80 mg / 1 mg)</em></li>
<li><em>UCa &gt; 4 mg / kg / day (or spot UCa/Cr &gt; 0.2) in type I RTA</em></li>
<li><em>USS / KUB (medullary nephrocalcinosis in type I RTA)</em></li>
<li><em>urinary citrate (low in type I RTA; high in type II / IV RTA)</em></li>
</ul></li>
</ul>
</div>
<div id="causes" class="section level3">
<h3><span class="header-section-number">6.5.4</span> Causes</h3>
<!-- +  pRTA (isolated)  -->
<!--     +  inherited  -->
<!--     +  acquired *topiramate*   -->
<!-- +  pRTA (with Fanconi)  -->
<!--     +  inherited *NBCe1A (AR with ocular abnormalities)*  -->
<!--     +  metabolic *Wilson's, cystinosis, fructose intolerance, Dent's, mitochondrial cytopathies*  -->
<!--     +  dysproteinaemia *myeloma, LCDD, LCFS is κ in 96 %, amyloid*  -->
<!--     +  tubulointerstitial *interstitial nephritis (inc. Sjogren's), allograft rejection*  -->
<!--     +  drugs *(Abx / cART)* *tenofovir, lamivudine, aminoglycosides, outdated tetracyclines*  -->
<!--     +  drugs *(other) cisplatin, valproate, lenalinomide*  -->
<!--     +  toxins *Pb, Hg, Cd, aristolochic acid*   -->
<!-- +  dRTA  -->
<!--     +  inherited *AEI (AR), H-ATPase B1 (AR with SNHL), H-ATPase A4 (AR)*  -->
<!--     +  tubulointerstitial *chronic pyelonephritis, chronic TIN, obstructive uropathy, sickle cell, rejection*  -->
<!--     +  autoimmune *hypergammaglobulinaemia, SLE, Sjogren's, chronic active hepatitis, PBC*  -->
<!--     +  drugs *Li^+^, amphoterecin, toluene*  -->
<!--     +  nephrocalcinosis *hyperPTH, idiopathic hypercalciuria, MSK*   -->
<!-- +  type IV  -->
<!--     +  low renin *DM, NSAIDs, CNIs, β--*  -->
<!--     +  high renin *Addisons, CAH, ACEi, ARB, heparin, ketoconazole*  -->
<!--     +  abnormal CD *TIN, spiro, amiloride, trimethoprim*   -->
<!-- +  type III  -->
<!--     +  inherited *CAII (AR with osteopetrosis / cerebral calcification)*  -->
<!--     +  acquired *topiramate (CA inhibition)*   -->
<table>
<tbody>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;vertical-align: top !important;" rowspan="2">
PRTA (ISOLATED)
</td>
<td style="text-align:left;font-style: italic;background-color: white !important;">
inherited
</td>
<td style="text-align:left;">
inherited
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;">
acquired
</td>
<td style="text-align:left;">
topiramate
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;vertical-align: top !important;" rowspan="24">
PRTA (WITH FANCONI)
</td>
<td style="text-align:left;font-style: italic;background-color: white !important;">
inherited
</td>
<td style="text-align:left;">
NBCe1A (AR with ocular abnormalities)
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="5">
metabolic
</td>
<td style="text-align:left;">
Wilson’s
</td>
</tr>
<tr>
<td style="text-align:left;">
cystinosis
</td>
</tr>
<tr>
<td style="text-align:left;">
fructose intolerance
</td>
</tr>
<tr>
<td style="text-align:left;">
Dent disease
</td>
</tr>
<tr>
<td style="text-align:left;">
mitochondrial cytopathies
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="4">
dysproteinaemia
</td>
<td style="text-align:left;">
myeloma
</td>
</tr>
<tr>
<td style="text-align:left;">
LCDD
</td>
</tr>
<tr>
<td style="text-align:left;">
LCFS is κ in 96 %,
</td>
</tr>
<tr>
<td style="text-align:left;">
amyloid
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="3">
TIN
</td>
<td style="text-align:left;">
Sjogren’s
</td>
</tr>
<tr>
<td style="text-align:left;">
other TIN
</td>
</tr>
<tr>
<td style="text-align:left;">
allograft rejection
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="4">
drugs (Abx / cART)
</td>
<td style="text-align:left;">
tenofovir
</td>
</tr>
<tr>
<td style="text-align:left;">
lamivudine
</td>
</tr>
<tr>
<td style="text-align:left;">
aminoglycosides
</td>
</tr>
<tr>
<td style="text-align:left;">
outdated tetracyclines
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="3">
drugs (other)
</td>
<td style="text-align:left;">
cisplatin
</td>
</tr>
<tr>
<td style="text-align:left;">
valproate
</td>
</tr>
<tr>
<td style="text-align:left;">
lenalinomide
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="4">
toxins
</td>
<td style="text-align:left;">
Pb
</td>
</tr>
<tr>
<td style="text-align:left;">
Hg
</td>
</tr>
<tr>
<td style="text-align:left;">
Cd
</td>
</tr>
<tr>
<td style="text-align:left;">
aristolochic acid
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;vertical-align: top !important;" rowspan="19">
DRTA
</td>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="3">
inherited
</td>
<td style="text-align:left;">
AEI (AR)
</td>
</tr>
<tr>
<td style="text-align:left;">
H-ATPase B1 (AR with SNHL)
</td>
</tr>
<tr>
<td style="text-align:left;">
H-ATPase A4 (AR)
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="5">
TIN
</td>
<td style="text-align:left;">
chronic pyelonephritis
</td>
</tr>
<tr>
<td style="text-align:left;">
chronic TIN
</td>
</tr>
<tr>
<td style="text-align:left;">
obstructive uropathy
</td>
</tr>
<tr>
<td style="text-align:left;">
sickle cell
</td>
</tr>
<tr>
<td style="text-align:left;">
allograft rejection
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="5">
autoimmune
</td>
<td style="text-align:left;">
hypergammaglobulinaemia
</td>
</tr>
<tr>
<td style="text-align:left;">
SLE
</td>
</tr>
<tr>
<td style="text-align:left;">
Sjogren’s
</td>
</tr>
<tr>
<td style="text-align:left;">
chronic active hepatitis
</td>
</tr>
<tr>
<td style="text-align:left;">
PBC
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="3">
drugs
</td>
<td style="text-align:left;">
Li+
</td>
</tr>
<tr>
<td style="text-align:left;">
amphoterocin
</td>
</tr>
<tr>
<td style="text-align:left;">
toluene
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="3">
nephrocalcinosis
</td>
<td style="text-align:left;">
hyperPTH
</td>
</tr>
<tr>
<td style="text-align:left;">
idiopathic hypercalciuria
</td>
</tr>
<tr>
<td style="text-align:left;">
MSK
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;vertical-align: top !important;" rowspan="12">
TYPE IV
</td>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="4">
low renin
</td>
<td style="text-align:left;">
DM
</td>
</tr>
<tr>
<td style="text-align:left;">
NSAIDs
</td>
</tr>
<tr>
<td style="text-align:left;">
CNIs
</td>
</tr>
<tr>
<td style="text-align:left;">
β–
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="5">
high renin
</td>
<td style="text-align:left;">
Addison’s
</td>
</tr>
<tr>
<td style="text-align:left;">
CAH
</td>
</tr>
<tr>
<td style="text-align:left;">
ACEi / ARB
</td>
</tr>
<tr>
<td style="text-align:left;">
heparin
</td>
</tr>
<tr>
<td style="text-align:left;">
ketoconazole
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;vertical-align: top !important;" rowspan="3">
abnormal CD
</td>
<td style="text-align:left;">
TIN
</td>
</tr>
<tr>
<td style="text-align:left;">
sprionolactone / amiloride
</td>
</tr>
<tr>
<td style="text-align:left;">
trimethoprim
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;background-color: white !important;vertical-align: top !important;" rowspan="2">
TYPE III
</td>
<td style="text-align:left;font-style: italic;background-color: white !important;">
inherited
</td>
<td style="text-align:left;">
CAII (AR with osteopetrosis / cerebral calcification)
</td>
</tr>
<tr>
<td style="text-align:left;font-style: italic;background-color: white !important;">
acquired
</td>
<td style="text-align:left;">
topiramate (CA inhibition)
</td>
</tr>
</tbody>
</table>
<p>Sjogrens classically causes a dRTA (but can also cause pRTA if interstitial nephritis).</p>
<p>Mitochondrial cytopathy: raised CK, abnormal number of microchondria (EM).</p>
<!-- ### Treatment -->
<!-- +  K citrate  -->
<!-- +  +/- NaHCO~3~  -->

</div>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="potassium.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="phosphate.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": null,
"toc": {
"collapse": "subsection"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
